Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Targetable pathways for drug repurposing in gastric cancer

  • Valero Almingol, Alba
  • Montori, Sheyla
  • Felípez, Nayra
  • Santamaría Martínez, Enrique
  • Fernández Irigoyen, Joaquín
  • Luzko, Irina
  • Cuestas, Anabella A
  • Pardo, Carlos
  • Prat, Richard
  • Moreira, Leticia
  • Albéniz Arbizu, Eduardo
Gastric cancer (GC) is both the fifth most common cancer worldwide and the fifth in mortality. Owing to a lack of symptoms in the early stages and unspecific clinical presentation in the later stages, GC is usually diagnosed at advanced stages. This means that only approximately 60% of patients are eligible for curative treatment, and overall, GC patients have a 5-year survival rate of only 28.3%, underscoring the importance of developing new treatment strategies. Drug repurposing involves identifying new therapeutic uses for approved drugs and is a promising strategy for cancer treatment because of its lower cost and faster development time. A variety of targetable pathways are involved in GC progression, including the mitogen-activated protein kinase, phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin, p53, Janus kinase 2/signal transducer and activator of transcription 3, hypoxia-inducible factor-1¿, wingless-type mouse mammary tumor virus integration site family/beta-catenin (Wnt/¿-catenin), nuclear factor kappa B, and Hippo pathways. Therefore, the repurposing of drugs targeting these pathways represents an interesting option in the search for new treatments for GC. In this review, we explore some relevant pathways involved in the development of GC and the possibilities of repurposing drugs that target them., Supported by the Instituto de Salud Carlos III, No. PI24/00784, No. PI24/00737, No. PI21/01181, No. PI21/00333 and No. INT22/00112; and Departamento de Universidad, Innovación y Transformación Digital Gobierno de Navarra, No. 0011-1408-2024-000011 and No. 0011-1408-2022-000010
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

The human gastric juice: a promising source for gastric cancer biomarkers

  • Felípez, Nayra
  • Montori, Sheyla
  • Mendizuri, Naroa
  • Llach, Joan
  • Delgado, Pedro G.
  • Moreira, Leticia
  • Santamaría Martínez, Enrique
  • Fernández Irigoyen, Joaquín
  • Albéniz Arbizu, Eduardo
Gastric cancer (GC) is a major public health problem worldwide, with high mortality rates due to late diagnosis and limited treatment options. Biomarker research is essential to improve the early detection of GC. Technological advances and research methodologies have improved diagnostic tools, identifying several potential biomarkers for GC, including microRNA, DNA methylation markers, and protein-based biomarkers. Although most studies have focused on identifying biomarkers in biofluids, the low specificity of these markers has limited their use in clinical practice. This is because many cancers share similar alterations and biomarkers, so obtaining them from the site of disease origin could yield more specific results. As a result, recent research efforts have shifted towards exploring gastric juice (GJ) as an alternative source for biomarker identification. Since GJ is a waste product during a gastroscopic examination, it could provide a “liquid biopsy” enriched with disease-specific biomarkers generated directly at the damaged site. Furthermore, as it contains secretions from the stomach lining, it could reflect changes associated with the developmental stage of GC. This narrative review describes some potential biomarkers for gastric cancer screening identified in gastric juice., This was supported by grants from Instituto de Salud Carlos III (PI21/00333 and PI21/01181). Nayra Felípez has a grant from Departamento de Universidad, Innovación y Transformación Digital. Gobierno de Navarra (Ref 0011-1408-2022-000010).